Gellai M, DeWolf R, Pullen M, Nambi P
Department of Renal Pharmacology, SmithKline Beecham Pharmaceuticals, King of Prussia, Pennsylvania.
Kidney Int. 1994 Nov;46(5):1287-94. doi: 10.1038/ki.1994.396.
Experiments were designed to compare the distribution and physiological roles of endothelin (ET) receptor subtypes, ETA and ETB, in the kidneys of normotensive Sprague-Dawley (SD) and spontaneously hypertensive (SH) rats. Using [125I] ET-1 and subtype-selective ligands sarafotoxin 6c (S6c, ETB-selective agonist) and BQ123 (ETA-selective antagonist), the distribution of ETA and ETB receptors in SD rat kidney cortex, outer medulla and papilla was calculated to be 50:50, 30:70 and 10:90, respectively. The ET receptor subtypes in outer medulla and papilla of age-matched SH rats were similar to those of SD. However, in the cortex of SH rats, the ratio of ETA to ETB was 25:75 compared to 50:50 in SD rats. In addition, the affinity of the ET receptors was also higher in SH rats (117 pM vs. 235 pM). In the conscious SD rats, bolus i.v. injections of ET-1 and S6c elicited similar dose-dependent decrease in renal blood flow (RBF), which were unaffected by the infusion of the selective ETA receptor antagonist, BQ123. The SH rats were more sensitive to the renal vasoconstrictor effect of S6c and ET-1. Also, the dose-response curve to S6c was shifted to the left when compared to ET-1; however, BQ123 infusion abolished this difference. In renal clearance studies, BQ123 infusions decreased RBF and glomerular filtration rate (GFR) only in SH rats, and the fractional excretion of sodium only in SD rats. The combined data indicate that the distribution and functional roles of ETA and ETB receptor subtypes are altered in the kidneys of SH rats.
实验旨在比较内皮素(ET)受体亚型ETA和ETB在正常血压的斯普拉格-道利(SD)大鼠和自发性高血压(SH)大鼠肾脏中的分布及生理作用。使用[125I]ET-1以及亚型选择性配体沙拉新6c(S6c,ETB选择性激动剂)和BQ123(ETA选择性拮抗剂),计算得出ETA和ETB受体在SD大鼠肾皮质、外髓质和乳头中的分布比例分别为50:50、30:70和10:90。年龄匹配的SH大鼠外髓质和乳头中的ET受体亚型与SD大鼠相似。然而,在SH大鼠的皮质中,ETA与ETB的比例为25:75,而SD大鼠为50:50。此外,SH大鼠中ET受体的亲和力也更高(117 pM对235 pM)。在清醒的SD大鼠中,静脉推注ET-1和S6c会引起相似的剂量依赖性肾血流量(RBF)下降,而选择性ETA受体拮抗剂BQ123的输注对此无影响。SH大鼠对S6c和ET-1的肾血管收缩作用更敏感。而且,与ET-1相比,S6c的剂量反应曲线向左移动;然而,BQ123的输注消除了这种差异。在肾清除率研究中,BQ123的输注仅使SH大鼠的RBF和肾小球滤过率(GFR)降低,仅使SD大鼠的钠排泄分数降低。综合数据表明,ETA和ETB受体亚型在SH大鼠肾脏中的分布和功能作用发生了改变。